您的位置: 首页 > 农业专利 > 详情页

Derivati 4-(indol-7-ilkarbonilaminometil)cikloheksan karboksilne kisline kot EP4 receptorski antagonisti, uporabni za zdravljenje kronične ledvične odpovedi ali diabetične nefropatije
专利权人:
ASTELLAS PHARMA INC.
发明人:
NOZAWA EISUKE,IBUKA RYOTARO,IKEGAI KAZUHIRO,MATSUURA KEISUKE,ZENKOH TATSUYA,SEO RYUSHI,WATANUKI SUSUMU,KAGEYAMA MICHIHITO,Nozawa Eisuke,Ibuka Ryotaro,Ikegai Kazuhiro,Matsuura Keisuke,Zenkoh Tatsuya,Seo Ryushi,Watanuki S
申请号:
SI200931064
公开号:
SI2565191T1
申请日:
2009.05.12
申请国别(地区):
SI
年份:
2014
代理人:
摘要:
[Problems] A compound, which is useful as an active ingredient of a pharmaceutical composition, for example, a pharmaceutical composition for treating chronic renal failure and/or diabetic nephropathy, is provided. [Solving Means] The present inventors have conducted extensive studies on a compound having an EP4 receptor antagonistic activity, and confirmed that the amide compound of the present invention has an EP4 receptor antagonistic activity, thereby completing the present invention. The amide compound of the present invention has an EP4 receptor antagonistic activity, and can be used as an active ingredient of a pharmaceutical composition for preventing and/or treating various EP4-related diseases, for example, chronic renal failure and/or diabetic nephropathy, and the like.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充